Conquer Cancer Logo

*Submission deadline extended to March 15, 2022 for the following YIA special competitions: YIA for Diversity and Inclusion in Breast Cancer Research and Mantle Cell Lymphoma

YIA for Invasive Lobular Carcinoma Research (funding for up to 2 years), applications due January 31, 2022 at 11:59pm ET

YIA in Medulloblastoma, applications due March 15, 2022 at 11:59pm ET

YIA in Ovarian Cancer, applications due January 31, 2022 at 11:59pm ET

The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor.  Applications in all areas of cancer research are accepted from U.S. and international applicants. 

The YIA is a one-year grant totaling $50,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants & Awards Ceremony at the ASCO Annual Meeting. Applicants who are selected to receive a YIA are allowed to receive other grants from other funding agencies. 


Applicants must meet the following criteria to qualify for a YIA:

  • Be a physician (MD, DO, or international equivalent) working in any country and currently in the last two years of his/her final subspecialty training at an academic medical institution and within 10 years of obtaining his/her medical degree at the time of grant submission. Examples of subspecialty training include, but are not limited to, a hematology-oncology fellowship, a surgical oncology fellowship, or a radiation oncology residency. An MD, PhD is eligible if both degrees are completed prior to the start of the grant period.
  • Be planning an investigative career in clinical oncology.
  • Have a valid, active medical license in the country where the research will be conducted at the time of application.
  • Be working in an oncology laboratory or clinical research setting. 
  • Have a mentor in the proposed research field from the sponsoring institution. The mentor must assume responsibility and provide guidance for the research. If the mentor is not an ASCO member, a supporting letter from an ASCO member from the sponsoring institution must be included.
  • Be able to commit at least 60% of full-time effort in research (applies to total research, not just the proposed project) during the award period.
  • Be an ASCO member or have submitted a membership application with the grant application. Apply for new membership, or renew an existing membership.
  • Eligible physicians are allowed to hold only one grant from Conquer Cancer at a time.

Applicants who are uncertain about their eligibility are encouraged to refer to the Eligibility section in this FAQ or contact for clarification and provide their full CV for evaluation. 

Funding Available

Conquer Cancer funds the most meritorious applications in all areas of cancer research. Awards are given based on individual merit and availability of funds. 

ASCO and Conquer Cancer are committed to fostering health equity in cancer research by improving diversity and inclusion in the oncology workforce, funding research focused on health disparities and bolstering funding for investigators from underrepresented populations in medicine and low and middle-income countries. 

In Conquer Cancer’s continued efforts to promote diversity and inclusion, funding is available for awards focusing on research in equity, diversity and health disparities. Applications focusing on these areas are strongly encouraged.  

Areas with Endowed and Dedicated Funding (as of October 28, 2021)

Conquer Cancer has endowed funding for certain areas that allows us to fund grants in these areas year after year. For 2022, dedicated funding is available in, but not limited to, the areas listed below. This list will be updated as new funding is confirmed. Conquer Cancer encourages applications in ALL areas of cancer research from U.S. and international applicants. 

A YIA Special Competition is open for applicants whose research project falls under the areas marked with an asterisk (*) below. The specific Request for Proposals (RFP) for each competition is provided.  Applicants with research projects focused on all other areas and those from other groups may download this RFP and apply to the YIA general competition. Applicants may only to submit one YIA application. 

  • Lobular Breast Cancer Alliance Young Investigator Award for Invasive Lobular Carcinoma Research* (special competition RFP) - due January 31, 2022 
  • Young Investigator Award for Diversity and Inclusion in Breast Cancer Research* (special competition RFP) due March 15, 2022 
  • Jose Baselga, MD, PhD, Young Investigator Award in Drug Development* (special competition RFP) - deadline extended to January 31, 2022
  • Dr. Jose Leis Endowed Young Investigator Award in Chronic Lymphocytic Leukemia* (special competition RFP) closed
  • Frist Family Endowed Young Investigator Award in Mantle Cell Lymphoma* in Honor of Howard A. Burris, III, MD (special competition RFP)  - deadline extended to March 15, 2022
  • Carson Leslie Foundation/#cureMEdullo Young Investigator Award (YIA) in Medulloblastoma* (special competition RFP) - deadline March 15, 2022
  • Susan & Teresa Schwab Ovarian Cancer Research Foundation Young Investigator Award (YIA) in Ovarian Cancer* (special competition RFP) - deadline January 31, 2022

Application Instructions

All application materials must be in English and must be submitted through the Application Portal. Paper applications or applications sent by e-mail or fax will not be accepted.

Open: Apply by March 15, 2022.

Application Deadlines

Application Open: 

July 1, 2021

Letter of Intent Deadline: 

Application Deadline: 

March 15, 2022

Award Term: 

July 1, 2022 to June 30, 2023


The Young Investigator Awards are supported by:

Daiichi-Sankyo Gateway for Cancer Research
Logo for Lobular Breast Cancer Alliance Massachusetts Society of Clinical Oncologists
Oncocyte Pfizer
Puma Biotechnology
Texas Society of Clinical Oncology Vaniam Group
What Would Willie Want      


ASCO State Affiliate Council and ASCO Clinical Practice Committee
Board Members of Conquer Cancer, ASCO and CancerLinQ
Nina Lesavoy Brady
Howard A. Burris, III, MD and Karen Y. Burris 
Marc L. Citron, MD
Conquer Cancer Research Fund
Dr. and Mrs. Thomas F. Frist, Jr., Mr. and Mrs. Charles and Trisha Elcan,Howard A. Burris, III, MD, and Sarah Cannon Research Institute
Friends, Colleagues, and Family of Joe Hogan
Friends and Family of Dr. Arti Hurria
Judith Salmon Kaur, MD
Kyowa Kirin, Inc. 
LA Kunkel Foundation
The Page & Otto Marx, Jr. Foundation
Georgia and Michael Michelson 
Victoria H. Montgomery
Greg Parekh/New Rhein Healthcare, LLC
The Phase Foundation
Thomas G. Roberts, Jr., MD, FASCO and Susan M. DaSilva, DNP
Colleagues, Friends, and Family of Dr. Gladys Rodriguez and Dr. Narjust Duma
Sapiente Family Foundation
Aaron and Barbro Sasson 
Susan & Teresa Schwab Ovarian Cancer Research Foundation
Shanken Family Foundation
Stephen A. Sherwin, MD
The Wawa Foundation
Friends and Family of Women Leaders in Pediatric Oncology
Generous Supporters of the Women Who Conquer Cancer

This list reflects commitments as of May 25, 2021.

This grant receives support that may result in a report to the CMS Open Payments website under the Physician Payments Sunshine Act. The supporting companies are required to report the amount of the grant, the names of physicians who are awarded this grant, and the names of their institutions. This information may appear on the Open Payments website. Find out more information about the Sunshine Act and CMS Open Payments program.